<<2 OR 3 undervalued biotechs under $300 million cap Do you care to share what the other 2 are? After today, you may have 6 or 7. Man, its bloody out there.>> INSM, HNAB, YMI, and SNUS come to mind. PANC is almost there and IDIX could be on its way.